Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
21.48
-1.00 (-4.43%)
At close: Nov 4, 2024, 4:00 PM
20.51
-0.97 (-4.52%)
After-hours: Nov 4, 2024, 5:30 PM EST
KNSA Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for KNSA stock have an average target of 34.6, with a low estimate of 30 and a high estimate of 40. The average target predicts an increase of 61.08% from the current stock price of 21.48.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for KNSA stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $30 → $35 | Buy | Maintains | $30 → $35 | +62.94% | Oct 30, 2024 |
| Jefferies | Jefferies | Strong Buy Initiates $40 | Strong Buy | Initiates | $40 | +86.22% | Sep 13, 2024 |
| Wedbush | Wedbush | Buy Maintains $30 → $34 | Buy | Maintains | $30 → $34 | +58.29% | Jul 23, 2024 |
| Wells Fargo | Wells Fargo | Buy Initiates $34 | Buy | Initiates | $34 | +58.29% | May 3, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $26 → $30 | Buy | Maintains | $26 → $30 | +39.66% | May 1, 2024 |
Financial Forecast
Revenue This Year
429.59M
from 270.26M
Increased by 58.95%
Revenue Next Year
585.17M
from 429.59M
Increased by 36.22%
EPS This Year
-0.21
from 0.20
EPS Next Year
0.63
from -0.21
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 461.0M | 643.8M | 751.7M | ||
| Avg | 429.6M | 585.2M | 695.9M | ||
| Low | 404.8M | 542.9M | 633.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 70.6% | 49.9% | 28.4% | ||
| Avg | 59.0% | 36.2% | 18.9% | ||
| Low | 49.8% | 26.4% | 8.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 0.04 | 1.00 | 1.28 | ||
| Avg | -0.21 | 0.63 | 0.78 | ||
| Low | -0.38 | 0.28 | 0.37 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -79.0% | - | 102.6% | ||
| Avg | - | - | 23.8% | ||
| Low | - | - | -41.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.